ANLONG BIO
Anlong Bio focuses on the research and development of nucleic acid drugs, including gene therapy, RNA drugs, and gene editing. The core team has experience in domestic and foreign scientific research, multinational pharmaceutical companies, entrepreneurship, and investment. In the fields with huge market potential, the varieties of independent intellectual property rights are developed, and most of them are at the forefront of the country. In the field of rare diseases, they use the rich resourc... es of rare disease patients in China to actively cooperate with foreign companies. The company aims to provide various genetic medicines to fulfill the unmet medical need in China, they develop AAV gene therapies with in-house technologies from vector discoveries to manufacturing and clinical approval.
ANLONG BIO
Social Links:
Industry:
Genetics Health Care Medical Pharmaceutical Therapeutics
Founded:
2019-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.anlongbio.com
Total Employee:
51+
Status:
Active
Contact:
86-10-80414166
Email Addresses:
[email protected]
Similar Organizations
ANLBIO
ANLBIO is a researcher and developer of adeno-associated virus-based gene therapy products.
Cell Products of National Engineering Research Center
Cell Products of National Engineering Research Center engages in the research and development of cell therapeutic products.
Ever Supreme Bio Technology
Ever Supreme Bio Technology is engaged in the research and development of cell gene therapies
Evergreen Therapeutics
Evergreen Therapeutics engages in the research and development of clinical drugs in the field of immunity and ophthalmology.
Haina Pharmaceuticals
Haina Pharmaceuticals engages in the research and development of drugs, biological sample testing, and drug registration.
Tyercan
Tyercan focuses on the research and development of innovative targeted anti-cancer and immunosuppressive drugs.
Current Employees Featured
Investors List
TaiKun Fund
TaiKun Fund investment in Series A - Anlong Bio
Shunchuang Industrial Investment Management Fund
Shunchuang Industrial Investment Management Fund investment in Series A - Anlong Bio
Official Site Inspections
http://www.anlongbio.com Semrush global rank: 12.95 M Semrush visits lastest month: 78
- Host name: 58.218.215.100
- IP address: 58.218.215.100
- Location: China
- Latitude: 32.0617
- Longitude: 118.7778
- Timezone: Asia/Shanghai

More informations about "Anlong Bio"
Anlongbio; Genetic Medicine in China; Gene Therapy-AAV
Upon AnlongBio’s inception, we raised $10 million in seed funding and quickly secured a network of highly experienced clinical, R&D, and manufacturing experts. By 2020, we established …See details»
AnlongBio 2025 Company Profile: Valuation, Funding & Investors
AnlongBio General Information Description. Developer of gene therapy technology intended to provide affordable and innovative treatments to patients. The company is mainly engaged in …See details»
Anlong Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 86-10-80414166 Anlong Bio focuses on the research and development of nucleic acid drugs, including gene therapy, RNA drugs, and …See details»
anlongbio - BIO International Convention 2025
AnlongBio actively pursues product and market collaborations with domestic and international pharmaceutical companies. Known for its efficiency, market orientation, and execution …See details»
Beijing Anlong Biomedical Co., Ltd. - Drug pipelines, Patents, …
Www.anlongbio.com. Private Company | 2019 | Beijing Shi, China | www.anlongbio.com. Last update 21 Feb 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & …See details»
Anlong Bio - VentureRadar
" AnlongBio aims to provide various genetic medicines to fulfill the unmet medical need in China, we develop AAV gene therapies with in-house technologies from vector discoveries to …See details»
AnLong Bio - LinkedIn
AnLong Bio | 148 followers on LinkedIn. Advancing Transformative Genetic Medicines for Patients | At Anlong Bio, patients are our priority. Since launching, our goal has been to deliver ...See details»
首页
2019. 安龙生物于2019年由著名投资人和企业家赵春林博士创立。赵春林博士对医疗保健和生命科学充满热情,并在三个基金中拥有丰富的经验,其中包括作为我们主要合作伙伴之一的安龙基 …See details»
安龙基因
安龙基因是由安龙生命科学基金携手清华大学医学院共同发起成立的高科技生物医药企业。公司以基因测序技术为核心,以临床精准诊疗为向导,兼顾体外诊断产品的研发、生产和销售,是一 …See details»
AnLong Bio Overview | SignalHire Company Profile
Phone Number +86-10-80414166: AnLong Bio industries Biotech: Headquarters Location: 10 Anxiang Street,Shunyi,Beijing, CN 10 Anxiang Street,Shunyi,Be... AnLong Bio Employees SizeSee details»
Beijing Anlong Biomedical Co., Ltd. - synapse.zhihuiya.com
了解Beijing Anlong Biomedical Co., Ltd. (北京安龙生物医药有限公司)公司的药物管线,治疗领域,技术平台,以及它的6项临床试验, 56篇新闻,疾病领域:内分泌与代谢疾病,感染,技术平 …See details»
Zhongguancun – Anlongbio – Genetic Medicine in China
It has built a close relationship with the nation's largest rare disease organization,the Chinese Organization for Rare Disorders, to lay the foundation for future product development and …See details»
Investors – Anlongbio – Genetic Medicine in China
Tigermed, a pioneer clinical Contract Research Organization (CRO) in China, dedicated to providing new drug research and clinical development services to global and Chinese …See details»
Company News – Anlongbio – Genetic Medicine in China
BEIJING, Sep 29,2021 — Anlong Biopharmaceutical Co., Ltd (AnlongBio),a gene therapy company in China, announced the appointment of Long Jiang, MD as chief medical …See details»
Corporate culture – Anlongbio – Genetic Medicine in China
At Anlong Bio, we are motivated problem solvers who believe that whatwe do matters. Our culture is driven by finding solutions and fosteringcollaboration to succeed together.See details»
Anlongbio – Genetic Medicine in China – Gene Therapy-AAV
Ding wei, phd. chief scientific officerSee details»
Anlong Biopharmaceutical Co., Ltd. - CMOCRO
Company. home; about us; how to subscribe; request listing; menu. home; about us; how to subscribe; request listingSee details»
Anlong Bio Announces $30 Million Series A Funding led by
Aug 31, 2021 On June 9th, 2021, Anlong Biopharmaceutical Co., Ltd (AnlongBio), a genetic medicine company in China, announced that it had completed a $30 Million Series A funding …See details»
anlongbio - BIO International Convention 2025
Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.See details»
AnLong Bio on LinkedIn: Anlong Bio Founder and CEO Adam Zhao ...
Anlong Bio Founder and CEO Adam Zhao participate MSQ Ventures's 2021 Cross-Border Healthcare Innovation & Partnership Summit to discuss opportunities for…See details»